Global Bioburden Testing Market Share

Statistics for the 2023 & 2024 Global Bioburden Testing market share, created by Mordor Intelligence™ Industry Reports. Global Bioburden Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Bioburden Testing Industry

The bioburden testing market consists of several major players such as Becton, Dickinson and Company, Charles River Laboratories Inc., Merck KGaA, Pacific BioLabs Inc., SGS SA, and others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them strengthen their market position. For instance, Charles River Laboratories is adopting an innovative technology platform for helping streamline bioburden testing. Additionally, Merck KGaA developed the product for testing bioburden and others, called EZ Fluo Rapid Detection, Ready-to-Use Culture Media.

Bioburden Testing Market Leaders

  1. Becton, Dickinson and Company

  2. Charles River Laboratories Inc.

  3. Merck KGaA

  4. Pacific BioLabs Inc.

  5. Sotera Health (Nelson Laboratories Inc.)

*Disclaimer: Major Players sorted in no particular order

Picture5.png

Bioburden Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)